Naxcel
Active substance
ATC code
Species
Pigs.
Indications
Treatment of bacterial respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis.
Treatment of septicaemia, polyarthritis or polyserositis associated with Streptococcus suis infection.
Dose to be administered and administration route
Intramuscular use.
Dose of 5 mg ceftiofur/kg body weight (equivalent to 1 ml of the veterinary medicinal product per 20 kg body weight) administered once in the neck by intramuscular injection.
Shake bottle vigorously for 30 seconds, or until all visual settlement has been resuspended.
To ensure a correct dosage, body weight should be determined as accurately as possible.
It is recommended to limit injection volumes to a maximum of 4 ml.
Adverse reactions
Pigs:
|
Very common (>1 animal / 10 animals treated): |
Injection site swelling1, Injection site skin discolouration2,3, Injection site blister2 |
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Anaphylactic-type reaction |
1Transient; following intramuscular injection.
2Have been observed for up to 42 days after injection and resolution has been observed at 56 days post injection.
3Less than 6 cm2.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
